Bone marrow neoplastic

Bone marrow - neoplastic myeloid

Myelodysplastic syndromes / neoplasms (MDS)

MDS unclassifiable

Last author update: 1 August 2011
Last staff update: 22 September 2023

Copyright: 2002-2024,, Inc.

PubMed Search: MDS unclassifiable

Nikhil Sangle, M.D.
Page views in 2023: 890
Page views in 2024 to date: 392
Cite this page: Sangle N. MDS unclassifiable. website. Accessed July 13th, 2024.
Definition / general
Myelodysplastic syndrome, unclassifiable (MDS-U) diagnosis can be made in 3 instances:
  1. Unequivocal dysplasia < 10% in one or more lineage, with cytogenetic abnormalities presumptive of MDS, and < 1% blasts in peripheral blood, 5% blasts in bone marrow
  2. Refractory anemia or refractory cytopenia with multilineage dysplasia with 1% blasts in peripheral blood
  3. Unilineage dysplasia with pancytopenia

  • Cases can be reclassified into specific subtypes later if characteristic features develop
  • Some cases are associated with prior aplastic anemia and monosomy 7 (Am J Clin Pathol 2006;126:925)
  • Myelofibrosis: when present, often is difficult to obtain bone marrow aspirate; patients often have pancytopenia with dysplasia in 3 lineages; CD34 staining helps identify blast population
Case reports
Microscopic (histologic) images

AFIP images

Pancytopenia, abnormally bilobed nuclei in granulocytes

Marked increase in megakaryocytes

Erythroid hyperplasia

Large erythroid precursors

Hypercellular marrow with marked fibrosis

Cluster of large megakaryocytes

Marked reduction in megakaryocytes

Recurrence with increased marrow cellularity

Images hosted on other servers:

Megakaryocyte clustering and hyperlobulated forms (figs 2 / 3)

Differential diagnosis
Back to top
Image 01 Image 02